Atlas Trials

Extension Study of TKT028 Evaluating Safety and Clinical Outcomes of Replagal® in Adult Patients With Fabry Disease

Clinical trial NCT01124643 · COMPLETED

Trial details

NCT number
NCT01124643
Sponsor
Shire
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Fabry Disease
Start date
2010-04-13
Primary completion
2013-07-08
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.